Home
About
Overview
Sharing Data
ORCID
Help
History (61)
Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors: A case series and literature review.
LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial.
Computerized analysis of abnormal asymmetry in digital chest radiographs: evaluation of potential utility.
Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer.
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.
See All 61 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014. J Thorac Oncol. 2015 Jan; 10(1 Suppl 1):S1-63.
View in:
PubMed
subject areas
Carcinoma, Non-Small-Cell Lung
Genetic Therapy
Humans
Immunotherapy
Lung Neoplasms
Molecular Targeted Therapy
Randomized Controlled Trials as Topic
authors with profiles
Thomas Hensing
Ravi Salgia